Related references
Note: Only part of the references are listed.A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2019)
Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study Cohort
Marco Falcone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
A rare cause of healthcare-associated infective endocarditis: Enterobacter cloacae
Omer Karasahin et al.
IDCASES (2018)
Infective Endocarditis
Michael Klein et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2016)
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association
Larry M. Baddour et al.
CIRCULATION (2015)
Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins
Yusuke Yoshino et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
Cefepime vs Other Antibacterial Agents for the Treatment of Enterobacter Species Bacteremia
Mark J. Siedner et al.
CLINICAL INFECTIOUS DISEASES (2014)
The Use of Cefepime for Treating AmpC β-Lactamase-Producing Enterobacteriaceae
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2013)
HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort
Stephen T. Chambers et al.
PLOS ONE (2013)
Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance
Maria Lina Mezzatesta et al.
FUTURE MICROBIOLOGY (2012)
An unusual etiology of infective endocarditis: Enterobacter cloacae
Juhi Moon et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Non-HACEK gram-negative bacillus endocarditis
Susan Morpeth et al.
ANNALS OF INTERNAL MEDICINE (2007)